FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2070003 · Received April 26, 2011

Report

Report Number
2134265-2011-01530
Event Type
Injury
Date Received
April 26, 2011
Date of Event
November 10, 2010
Report Date
March 29, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS COMBINATION PRODUCT (B)(6). DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4) .

Description of Event or Problem · 1

(B)(4) CLINICAL STUDY. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION. THE PATIENT PRESENTED DUE TO UNSTABLE ANGINA (B)(6) AND UNDERWENT CARDIAC CATHETERIZATION WHICH REVEALED AN 85% STENOSED AND 22 MM LONG TARGET LESION IN THE MID LEFT ANTERIOR DESCENDING CORONARY ARTERY (LAD) WITH A REFERENCE VESSEL DIAMETER OF 3.0MM. IT WAS TREATED WITH DIRECT STENT PLACEMENT USING A 3.0X24MM TAXUS LIBERTE STENT AND POST DILATION RESULTING IN 9% RESIDUAL STENOSIS. ONE DAY LATER, THE PATIENT DEVELOPED CHEST PAIN AND DYSPNEA. CARDIAC ENZYMES WERE FOUND TO BE ELEVATED AND THE PATIENT WAS DIAGNOSED AS HAVING A MYOCARDIAL INFARCTION. NO TREATMENT WAS NOTED AND THE EVENT RESULTED IN A PROLONGED HOSPITALIZATION. ONE DAY LATER, THE EVENT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECTS AND THE PATIENT WAS DISCHARGED ON ASPIRIN AND PRASUGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893724300 13626880

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization